Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome  Megan Rossi, Raphael Aggio,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
The Role of Psychosocial Care in Adapting to Health Care Reform
An Unusual Cause of Small Bowel Obstruction: A Plastic Glove
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Saurabh Dawra, Vishal Sharma, Usha Dutta 
Ezekiel Wong Toh Yoon, Kazuki Nishihara 
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
A Rare Cause of Life-Threatening Upper Gastrointestinal Bleeding
Pichamol Jirapinyo, Christopher C. Thompson 
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
James W.T. Toh, Hasitha Balasuriya, Peter Stewart 
Shou–Jiang Tang, Feriyl Bhaijee 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Katsunori Matsueda, Tatsuya Toyokawa 
Morgagni's Hernia Clinical Gastroenterology and Hepatology
A Shocking Cystory Clinical Gastroenterology and Hepatology
Portal Hypertensive Enteropathy in Small-Bowel Capsule Endoscopy
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Volume 153, Issue 4, Pages (October 2017)
An Unusual Cause of Small Bowel Obstruction: A Plastic Glove
Proximal Esophageal Varices: A Rare Yet Treatable Cause of Hemorrhage
Jessica L. Mellinger, Michael L. Volk 
Activity-Based Costing and Management in a Hospital-Based GI Unit
Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A
The Effects of Dietary Fat and Calorie Density on Esophageal Acid Exposure and Reflux Symptoms  Mark Fox, Carole Barr, Suzanne Nolan, Miranda Lomer, Angela.
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea  Reginald V. Fant,
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year  Jasmine K. Zia, Pamela Barney,
Rohan M. Modi, Christina A. Arnold, Peter P. Stanich 
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Abnormal Liver Tests and Fatty Liver on Ultrasound
New Models of Gastroenterology Practice
Dushyant Singh, Reetu Singh, Wendell K. Clarkston 
Meckel’s Diverticulum on Small-Bowel Follow-Through Series and Computerized Tomography Scan in a 7-Year-Old Boy With Anemia  Cary M. Qualia, George T.
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Cholelithiasis in a Patient With History of Cholecystectomy
Lisa I. Backus, Derek B. Boothroyd, Barbara R
Rebecca M. Lovell, Alexander C. Ford 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Alan Bonder, MD, Nezam H. Afdhal, MD 
Risk of Irritable Bowel Syndrome After an Episode of Bacterial Gastroenteritis in General Practice: Influence of Comorbidities  Ana Ruigómez, Luis Alberto.
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Rosanne M. Furse, Caroline J. Green, Anthony S. Mee 
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome  Luise M. Begtrup, Anne Line Engsbro,
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Preeth Jayaram, Alex Shindel, James Buxbaum 
GI Bleeding, Colon Varicosities, and Visceral Enlargement as a Manifestation of Klippel– Trenaunay Syndrome  Fnu Deepinder  Clinical Gastroenterology and.
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Issue Highlights Clinical Gastroenterology and Hepatology
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Klaus Mönkemüller, Helmut Neumann, Lucia C. Fry 
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Presentation transcript:

Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome  Megan Rossi, Raphael Aggio, Heidi M. Staudacher, Miranda C. Lomer, James O. Lindsay, Peter Irving, Chris Probert, Kevin Whelan  Clinical Gastroenterology and Hepatology  Volume 16, Issue 3, Pages 385-391.e1 (March 2018) DOI: 10.1016/j.cgh.2017.09.055 Copyright © 2018 AGA Institute Terms and Conditions

Figure 1 PCA of fecal samples from patients responding and not responding to LFD or probiotic before and after intervention. (A) Baseline samples from the LFD group; (B) baseline samples from the probiotic group; (C) end-of-intervention samples from the LFD group; (D) end-of-intervention samples from the probiotic group. Clinical Gastroenterology and Hepatology 2018 16, 385-391.e1DOI: (10.1016/j.cgh.2017.09.055) Copyright © 2018 AGA Institute Terms and Conditions